Information  X 
Enter a valid email address

Alliance Pharma PLC Ord 1P (APH)

Related News

27-May-2015 07:46 AM

Alliance revenues up

Alliance Pharma's trading in the first four months of this year has been satisfactory with revenues 6% up at £15.6m, shareholders at the annual general meeting today will be told. Chairman Andrew Smith will say: "Hydromol, our biggest brand,
20-Apr-2015 09:20 AM

Alliance Pharma 'set for resumption in growth'

Hardman & Co has issued a research report on Alliance Pharma which says the company is set for a resumption in growth. The report says: "Alliance Pharma released a solid set of full year numbers, demonstrating the resilience of its underlying core b
10-Apr-2015 08:59 AM

Alliance Pharma schedules AGM

Alliance Pharma will hold its annual general meeting on 27 May. At 8:59am: (LON:APH) Alliance Pharma PLC share price was 0p at 39.75p Story provided by StockMarketWire.com...
25-Mar-2015 09:22 AM

Alliance pre-tax profits fall

Alliance Pharma's revenues fell to £43.5m in the year to the end of December (2013: £45.3m) and pre-tax profits dropped to £10.8m from £12.0m. The proposed final dividend of 0.667p per share is up 10% taking the total for the year to 1.000p per
17-Feb-2015 09:44 AM

Alliance Pharma FD to step down

Alliance Pharma finance director Richard Wright is to leave the company after nearly eight years in the role to pursue other opportunities. He will remain in his role until 31 May. A search process for a new FD has begun and the company will provide an
02-Feb-2015 12:24 PM

Alliance Pharma acquires MacuVision

Alliance Pharma, the speciality pharmaceutical company, has announced that its wholly owned subsidiary Alliance Pharmaceuticals Limited has acquired MacuVision Europe for initial consideration of £5.5 million plus the net asset value of MacuVision at com
26-Jan-2015 09:40 AM

Procserve CEO joins Alliance Pharma board

Alliance Pharma has appointed Nigel Clifford as an independent non-executive director with immediate effect. Clifford is chief executive of Procserve Holdings Limited, a leading company in enabling secure transactions online. He is also currently a non-
19-Jan-2015 07:33 AM

Alliance Pharma on track

Alliance Pharma expects pre-tax profits for the year ended 31 December to be in line with current market expectations. Turnover is expected to be £43.5m (2013: £45.3m after restatement following the adoption of IFRS 11). Sales of the Hydromol derma
19-Jan-2015 07:14 AM

Alliance Pharma on track

Story provided by StockMarketWire.com...
18-Dec-2014 03:35 PM

Alliance Pharma non-exec to step down

Alliance Pharma, the speciality pharmaceutical company, confirms that, further to the announcement on 30 December 2013, Paul Ranson will retire from his position as non-executive director on 31 December. At 3:35pm: (LON:APH) Alliance Pharma PLC share pr
10-Sep-2014 09:03 AM

Alliance Pharma on track despite fall in H1 profits

Alliance Pharma, the speciality pharmaceutical company, posts pre-tax profit of £5.4m for the six months to the end of June. Alliance Pharma says this was down from £6.8m a year ago when its cyclical toxicology product was reaching the peak of its sa
05-Aug-2014 09:31 AM

Alliance Pharma schedules interims

Alliance Pharma will announce its interim results for the six months ended 30 June on 10 September. At 9:31am: (LON:APH) Alliance Pharma PLC share price was 0p at 34p Story provided by StockMarketWire.com...
09-Jul-2014 08:10 AM

Alliance Pharma in line with expectations

Alliance Pharma's trading for the six months to the end of June has been in line with management's expectations. Alliance says total turnover - including joint ventures - was approximately £22.5m (2013: £22.8m). Group turnover excluding sha
21-May-2014 08:43 AM

Alliance Pharma in line with expectations

Speciality pharmaceutical company Alliance Pharma's trading is in line with expectations, shareholders at the annual general meeting today will be told. Chairman Michael Gatenby - who will step down at the end of the AGM - will say: "Following
26-Mar-2014 07:35 AM

Alliance profits rise

Speciality pharmaceutical company Alliance Pharma reported revenue up 1% to £45.5m in the year to end-December, with pre-tax profit up 11% to £12m. �€¢ Basic EPS up 6% to 3.82p (2012: 3.61p) �€¢ Free cash flow
04-Feb-2014 09:56 AM

Alliance Pharma schedules FY results

Speciality pharmaceutical company Alliance Pharma will announce its preliminary results for the year to the end of December on 26 March. At 9:56am: (LON:APH) Alliance Pharma PLC share price was -0.25p at 32.88p Story provided by StockMarketWire.com..
14-Jan-2014 08:23 AM

Alliance acquires rights to Irenat

Alliance Pharma subsidiary Alliance Pharmaceuticals has acquired the rights to the thyroid product Irenat from subsidiaries of Bayer AG. Irenat, a sodium perchlorate monohydrate, is marketed in Germany and is mainly used for diagnosing and treating hype
14-Jan-2014 07:27 AM

Alliance in line with market forecasts

Alliance Pharma expects turnover for 2013 to be £45.5m (2012: £44.9m) with pre-tax profits in line with current market expectations. Sales of the Hydromol dermatology range grew from £4.7m in 2012 to £5.3m in 2013. The Opus Group stoma care busine
18-Dec-2013 08:00 AM

Alliance acquires rights to Lypsyl

Alliance Pharma, the speciality pharmaceutical company, has acquired all UK and Republic of Ireland rights to Lypsyl from Novartis for US$3.0m. The rights have been acquired by Alliance's wholly-owned subsidiary Alliance Pharmaceuticals Limited. L
11-Oct-2013 07:32 AM

Alliance Pharma in £55m refinancing

Alliance Pharma has successfully negotiated new enlarged bank facilities of £55m with Lloyds Bank and Royal Bank of Scotland on improved terms. The new facilities, which immediately replace the existing facilities and will be available until 30 June 201
11-Sep-2013 07:50 AM

Dividend hiked after strong first half at Alliance Pharma

Alliance Pharma (AIM: APH), the speciality pharmaceutical company, has announced that sales for the six months ended 30 June 2013 were up 4% to £22.8m (H1 2012: £22.0m) The company says that Hydromol�?¢ continues to grow well and is now a £5m bra
27-Aug-2013 03:42 PM

Alliance Pharma in CULS conversion

Alliance Pharma has allotted 223,809 ordinary shares following the conversion of £47,000 nominal value of the company's 8% convertible unsecured loan stock. At 3:42pm: (LON:APH) Alliance Pharma share price was -0.13p at 35p Story provided b
11-Jul-2013 07:58 AM

Alliance Pharma turnover up 4%

Alliance Pharma's first half trading has been in line with management's expectations with turnover of approximately £22.8m (H1 2012: £22.0m). The group said turnover increased by 4% despite the unavailability of ImmuCyst (H1 2012: £1.6m), wh
06-Jun-2013 07:38 AM

Alliance unit acquires rights to Syntometrine

Alliance Pharma's wholly-owned subsidiary Alliance Pharmaceuticals has acquired all existing rights to Syntometrine from Novartis AG and Novartis Pharma AG for a consideration of $11.5m. Alliance already owns the UK rights to Syntometrine, an obst
22-May-2013 08:36 AM

Alliance Pharma looks to make acquisitions

Alliance Pharma, the speciality pharmaceutical company, is continuing to assess a number of acquisition opportunities and remains confident of bringing further transactions to completion in the near future." Michael Gatenby, the company's chai
 
Headlines
Top categories
Company finder